In the landscape of global Islamic economy, Oman has long been recognized for its thoughtful, measured approach to development. But in 2026, the Sultanate is making headlines for something new: its ambitious emergence as a hub for halal pharmaceutical manufacturing.
While Malaysia and the UAE have dominated conversations about halal hubs, Oman has been quietly building something remarkable. With a comprehensive National Halal System framework now in place, pharmaceutical manufacturing under the supervision of the Ministry of Health, and major new facilities like the $150 million Philex factory opening in Salalah, Oman is positioning itself as a trusted source of Shariah-compliant medicines for the GCC, the Arab world, and beyond .
This guide explores the rapidly evolving landscape of halal pharmaceutical companies in Oman. We will examine the regulatory framework driving this growth, profile the key manufacturers operating in the Sultanate, analyse the market opportunities and challenges, and explore what the future holds for this emerging sector.
Why Oman? The Strategic Foundation for Halal Pharma
Oman’s pursuit of halal pharmaceutical manufacturing leadership is not accidental. It rests on three strategic pillars.
1. The National Halal System: A Comprehensive Framework
In December 2025, Oman’s National Halal System Task Force convened for its third meeting to review progress on the development and launch of an integrated halal framework . This initiative, championed by the Ministry of Commerce, Industry and Investment Promotion, is designed to enhance the global competitiveness of Omani products and ensure their compliance with both domestic and international market standards.
The meeting was chaired by Dr. Saleh bin Said Masan, Undersecretary for Commerce and Industry, and included representatives from key government bodies. Critically, the task force identified pharmaceuticals as one of three core sectors to be governed by the new framework, alongside cosmetics and food/water .
Oman’s Halal Governance Structure:
| Sector | Oversight Body |
|---|---|
| Pharmaceuticals | Ministry of Health |
| Food and Water | Ministry of Agriculture, Fisheries and Water Resources |
| Cosmetics | Ministry of Commerce, Industry and Investment Promotion |
*Source: Oman News Agency, December 2025 *
This sector-specific governance ensures that pharmaceutical halal certification is handled by professionals who understand the unique complexities of drug manufacturing—from active pharmaceutical ingredients (APIs) to finished formulations.
2. The Shariah Authority: The Office of the Grand Mufti
What sets Oman’s approach apart is the explicit recognition of religious authority. The task force affirmed the central role of the Office of the Grand Mufti as the definitive Sharia authority for interpreting halal requirements . This ensures that the system remains aligned with Oman’s established religious principles and maintains regulatory coherence.
The Undersecretary stressed the necessity of establishing clear procedures for periodic Sharia compliance audits of certified products and services, complemented by technical experts to enhance supply chain oversight and verify product integrity .
3. The Global Halal Economy: A $10 Trillion Opportunity
The global halal economy is experiencing unprecedented growth. According to data presented at the task force meeting, the market is now valued at over $7 trillion, with projections indicating it will reach approximately $10 trillion by 2030 . This expansive market encompasses diverse sectors including:
- Halal food
- Personal care and cosmetics
- Halal tourism
- Islamic finance
- Modest fashion
- Pharmaceuticals
Oman’s strategic position—at the crossroads of the GCC, Africa, and Asia—makes it an ideal manufacturing and logistics hub to serve these growing markets.
Oman’s Halal Pharmaceutical Manufacturers: Key Players
Philex Pharmaceuticals: A $150 Million Landmark
The most significant development in Oman’s halal pharmaceutical sector in 2026 is the opening of the Philex Pharmaceuticals manufacturing factory in the Salalah Free Zone .
The Opening:
Inaugurated on January 25, 2026, under the patronage of Dr. Hilal Ali Al Sabti, Minister of Health, the factory represents a landmark investment in the Sultanate’s pharmaceutical capabilities . The project’s total investment value reaches $150 million across its three development stages.
Production Capacity:
| Phase | Investment | Production Capacity |
|---|---|---|
| Phase 1 | $60 million (RO 23 million) | 1 billion tablets + 1 billion capsules (50 medicinal items) |
| Phases 2-3 | $90 million (additional) | Expansion of production lines, including vaccines |
*Source: Oman News Agency, January 2026 *
In its current stage, the manufacturer plans to produce more than 100 pharmaceuticals, including various types of medicines and vaccines in subsequent stages. The facility is built according to international standard specifications, ensuring quality and safety for both local and export markets.
Market Reach:
The factory’s drug products are already being marketed in Oman, Qatar, and other countries . It aims to export locally manufactured products to the GCC and Arab countries, as well as the African market in the near future.
Strategic Significance:
Dr. Ali Masoud Al Sunaidy, Chairman of the Public Authority for Special Economic Zones and Free Zones (OPAZ), described the opening as “an added value to the pharmaceutical and medical industries in general in the Sultanate of Oman, and particularly in the free and industrial zones in Dhofar Governorate” .
With the opening of Philex, Salalah Free Zone is positioned to become a regional center for pharmaceutical and biological industries.
Drug Manufacturing Company (DMC): The Pioneer in Sohar
While Philex represents the new wave, the Drug Manufacturing Company (DMC) represents the foundation. Established with financing from Meethaq (Bank Muscat’s Islamic banking arm), DMC set up a manufacturing unit in Sohar Industrial Area .
Capabilities:
- Installed Capacity: 420 tonnes annually
- Products: Active pharmaceutical ingredients (APIs), intermediates, and formulations
- Expertise: Promoters bring experience from similar pharmaceutical projects in Oman and India
The Islamic Finance Connection:
The involvement of Meethaq in financing DMC is significant. Sulaiman Al Harthy, Deputy CEO of Islamic Banking at Bank Muscat, noted that the partnership reflects “Oman’s strategic economic diversification programme and the emergence of Islamic financial services industry” . This integration of Islamic finance with pharmaceutical manufacturing creates a fully Shariah-compliant ecosystem from financing through production.
The Broader Pharmaceutical Ecosystem
Beyond these two major players, Oman’s pharmaceutical and medical manufacturing sector is expanding rapidly. According to OPAZ data, the total existing investments in pharmaceutical and medical factories in Salalah Free Zone and Raysut Industrial Zone now approach $200 million, distributed across 7 factories .
| Zone | Facilities | Investment Value |
|---|---|---|
| Salalah Free Zone | Philex + 2 additional projects (medical tools, medical supplies) | $95 million |
| Raysut Industrial City | 4 factories (injectable solutions, pharmaceuticals, medical gloves, medical supplies) | $104 million |
| Total | 7 factories | ~$200 million |
*Source: OPAZ, January 2026 *
The Halal Ingredients Market: Foundation for Pharma Growth
Behind every halal pharmaceutical product lies the critical question of ingredients. Oman’s halal ingredients market is projected to see steady growth through 2031, driven by increasing consumer awareness and demand for halal-certified products .
Market Drivers
According to 6Wresearch’s analysis of the Oman Halal Ingredients Market (2025-2031), several factors are fueling expansion :
- Growing Muslim Population: Both in Oman and the region, creating sustained demand for halal-certified products
- Rising Awareness: Consumers are becoming more conscious about the origin and contents of their pharmaceuticals
- Government Initiatives: The Omani government provides incentives and support to local halal businesses
- International Trade: Agreements and collaborations with global halal ingredient suppliers are boosting market access
Market Segments
The market analysis identifies three key application segments for halal ingredients :
| Application Segment | Description |
|---|---|
| Food & Beverage | Largest segment, but pharmaceutical segment growing rapidly |
| Pharmaceuticals | Critical growth area for halal-certified ingredients |
| Cosmetics | Expanding segment with increasing halal awareness |
Market Challenges
The report also identifies challenges that halal pharmaceutical companies must navigate :
- Limited Awareness: Some consumers and businesses lack understanding of halal certification, potentially affecting trust
- Supply Chain Adherence: Ensuring consistent halal compliance throughout the supply chain can be challenging, especially for smaller enterprises
- Regulatory Complexities: Varying interpretations of halal requirements across different markets
- Cost Barriers: Specialized certification and documentation can increase production costs
Overcoming Challenges
The report emphasizes that overcoming these challenges requires:
- Increased Education about halal principles and certification
- Standardization of halal practices across the industry
- Transparent Communication to build credibility with consumers and trading partners
Oman’s National Halal System directly addresses these challenges by establishing clear regulatory frameworks, standardized procedures, and a definitive Sharia authority .
Export Potential: Oman as a Regional Halal Pharma Hub
One of the most compelling aspects of Oman’s halal pharmaceutical sector is its export orientation. The National Halal System is explicitly designed to “enhance the global competitiveness of Omani products” and support exporters requiring halal certification .
Target Markets
Omani pharmaceutical manufacturers are strategically positioned to serve:
1. GCC Countries: With harmonized regulatory standards and proximity, GCC markets are the natural first step. Philex is already marketing products in Qatar alongside Oman .
2. Arab Countries: The broader Arab world, with its large Muslim population and growing demand for halal-certified products, represents a significant opportunity.
3. African Markets: OPAZ Chairman Al Sunaidy explicitly noted the potential for exporting to African markets . Salalah’s location on the Arabian Sea makes it an ideal gateway to East Africa.
Competitive Advantages
Omani halal pharmaceutical manufacturers possess several unique advantages:
- Government Backing: Active support from multiple ministries and the Public Authority for Special Economic Zones
- Shariah Clarity: Definitive religious authority through the Office of the Grand Mufti
- International Standards: Factories built according to international specifications
- Integrated Ecosystem: Islamic financing (through Meethaq) supporting halal manufacturing
- Strategic Location: Proximity to major export markets
How Halal Pharmaceutical Certification Works in Oman
For companies seeking to manufacture or import halal pharmaceuticals in Oman, the certification process is now becoming standardized under the National Halal System.
The Process
- Application: Manufacturers submit applications through the Oman Business Platform, designated as the official portal for halal certification applications .
- Oversight: The Ministry of Health oversees pharmaceutical certification, ensuring alignment with both medical safety standards and halal requirements .
- Shariah Review: The Office of the Grand Mufti provides definitive interpretation of halal requirements, ensuring religious compliance .
- Audit: Periodic Shariah compliance audits verify ongoing adherence to both regulatory and religious standards .
- Certification: Approved products receive halal certification, enabling access to local and international halal markets.
Fast Track Mechanism
To streamline market access, the task force reviewed a ‘Fast Track’ application mechanism set for implementation to facilitate the entry of halal products into local and international markets, bolster consumer confidence, and support Omani exporters .
International Alignment
Oman is considering potential membership in the Standards and Metrology Institute for the Islamic Countries (SMIIC) to benefit from expertise in standardization, particularly for halal . SMIIC membership would align Omani standards with those of other OIC member countries, facilitating exports across the Islamic world.
Investment Opportunities in Halal Pharma Oman
For investors, Oman’s halal pharmaceutical sector offers multiple entry points.
1. Manufacturing Facilities
With Salalah Free Zone positioning itself as a regional center for pharmaceutical and biological industries, and lands allocated for expansion, there are opportunities for new manufacturing facilities . The total investment in pharmaceutical and medical factories in the region has reached $200 million, with room for further growth.
2. Halal Ingredients Supply
The growing demand for halal-certified pharmaceutical ingredients creates opportunities for suppliers of:
- Halal-certified excipients
- Halal gelatin (for capsules)
- Halal enzymes
- Other pharmaceutical-grade halal ingredients
3. Research and Development
Philex’s development includes a research and development center . Additional R&D investment could focus on:
- Developing new halal pharmaceutical formulations
- Alternative ingredients for non-halal excipients
- Testing and verification methodologies
4. Logistics and Distribution
As Omani manufacturers expand exports, demand for halal-certified logistics services—including dedicated storage and transportation—will grow.
The Future Outlook: 2026 and Beyond
As we progress through 2026, several trends will shape the future of halal pharmaceutical companies in Oman:
National Halal System Implementation: With the framework now in place, 2026 will see the full rollout of certification procedures, fee structures, and the Fast Track mechanism .
Export Expansion: Philex and other manufacturers will continue expanding their export markets, with Africa representing a particularly significant opportunity .
International Partnerships: Oman’s potential SMIIC membership would open new avenues for technical cooperation and market access .
Product Portfolio Growth: Philex’s plan to produce more than 100 pharmaceuticals, including vaccines, will significantly expand the range of halal-certified medicines available .
Consumer Awareness: As awareness of halal pharmaceuticals grows, domestic demand will strengthen, creating a virtuous cycle of investment and innovation.
Practical Guidance for Buyers and Partners
For International Pharmaceutical Buyers
If you are seeking halal-certified pharmaceutical products:
- Verify Certification: Ensure that products are certified under Oman’s National Halal System, with oversight from the Ministry of Health and approval from the Office of the Grand Mufti .
- Engage with Major Manufacturers: Philex Pharmaceuticals and Drug Manufacturing Company are the primary halal pharmaceutical manufacturers in Oman .
- Understand Export Capabilities: Both manufacturers have export ambitions—Philex is already serving Qatar and aims to reach GCC, Arab, and African markets .
For Potential Investors
- Explore Free Zone Opportunities: Salalah Free Zone offers land allocations for pharmaceutical and medical factories .
- Leverage Government Support: The Omani government provides incentives and support for halal industry development .
- Partner with Local Experts: Consider partnerships with existing manufacturers or local investors familiar with the regulatory landscape.
For Healthcare Providers
- Source Locally: With expanding local manufacturing capacity, consider sourcing halal-certified pharmaceuticals from Omani manufacturers to support the local economy.
- Verify Compliance: Ensure that products carry appropriate certification from recognized bodies under the National Halal System.
Conclusion: Oman’s Halal Pharma Moment
The global halal economy is approaching $10 trillion, and pharmaceuticals represent one of its most critical and complex sectors . In this landscape, Oman is emerging not as a follower but as a pioneer—building a comprehensive national halal system with pharmaceutical manufacturing at its core.
From the pioneering Drug Manufacturing Company in Sohar to the landmark $150 million Philex factory in Salalah, from clear Shariah authority through the Office of the Grand Mufti to streamlined certification through the Oman Business Platform, the infrastructure for halal pharmaceutical excellence is in place .
For buyers seeking trusted halal medicines, for investors looking for strategic opportunities, and for patients desiring pharmaceuticals aligned with their faith, Oman offers something increasingly rare: a system built on clarity, integrity, and a vision of serving both local needs and global markets.
The factories are open. The regulatory framework is operational. The export markets are waiting. Oman’s halal pharmaceutical moment has arrived.
Oman Halal Pharmaceutical Sector At-a-Glance (2026)
| Element | Details |
|---|---|
| Regulatory Authority | Ministry of Health (pharmaceuticals) |
| Shariah Authority | Office of the Grand Mufti |
| Application Portal | Oman Business Platform |
| Major Manufacturer | Philex Pharmaceuticals ($150M, Salalah) |
| Pioneer Manufacturer | Drug Manufacturing Company (Sohar) |
| Total Sector Investment | ~$200 million (7 factories) |
| Production Capacity (Philex) | 1B tablets + 1B capsules (Phase 1) |
| Target Markets | GCC, Arab countries, Africa |
Are you sourcing halal pharmaceuticals from Oman? Share your experience in the comments below.